↓ Skip to main content

Efficacy Results of a Trial of a Herpes Simplex Vaccine

Overview of attention for article published in New England Journal of Medicine, January 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Readers on

mendeley
270 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Published in
New England Journal of Medicine, January 2012
DOI 10.1056/nejmoa1103151
Pubmed ID
Authors
Abstract

Two previous studies of a herpes simplex virus type 2 (HSV-2) subunit vaccine containing glycoprotein D in HSV-discordant couples revealed 73% and 74% efficacy against genital disease in women who were negative for both HSV type 1 (HSV-1) and HSV-2 antibodies. Efficacy was not observed in men or HSV-1 seropositive women.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 270 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 2 <1%
South Africa 1 <1%
Tanzania, United Republic of 1 <1%
Singapore 1 <1%
Korea, Republic of 1 <1%
France 1 <1%
Ecuador 1 <1%
Chile 1 <1%
Unknown 261 97%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 56 21%
Student > Ph. D. Student 43 16%
Student > Bachelor 26 10%
Other 20 7%
Student > Master 19 7%
Other 48 18%
Unknown 58 21%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 72 27%
Agricultural and Biological Sciences 52 19%
Biochemistry, Genetics and Molecular Biology 27 10%
Immunology and Microbiology 23 9%
Pharmacology, Toxicology and Pharmaceutical Science 5 2%
Other 19 7%
Unknown 72 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 101. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2025.
All research outputs
#516,502
of 32,824,291 outputs
Outputs from New England Journal of Medicine
#6,928
of 37,559 outputs
Outputs of similar age
#2,483
of 293,950 outputs
Outputs of similar age from New England Journal of Medicine
#36
of 262 outputs
Altmetric has tracked 32,824,291 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 37,559 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 119.9. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,950 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 262 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.